Dingdang Health Technology Group (9886) Fundamentals 2026 — Revenue Analysis | SniperIQ
Dingdang Health Technology Group (9886) is a CN-listed Healthcare company in Medical - Distribution with a market capitalization of HK
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Dingdang Health Technology Group's market cap?
Dingdang Health Technology Group (9886) has a market capitalization of approximately HK
What is Dingdang Health Technology Group's P/E ratio?
Dingdang Health Technology Group's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Dingdang Health Technology Group?
Dingdang Health Technology Group runs a net profit margin of -1.0%, a gross margin of 35.3%, and an operating margin of -1.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Dingdang Health Technology Group generate?
Dingdang Health Technology Group reported revenue of ¥4.9B for fiscal year 2025, with net income of -¥49M and earnings per share (EPS) of -0.0377. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Dingdang Health Technology Group pay a dividend?
Dingdang Health Technology Group does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Dingdang Health Technology Group financially healthy?
Dingdang Health Technology Group carries a debt-to-equity ratio of 0.17x and a current ratio of 2.28x, with a market beta of 0.96. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Dingdang Health Technology Group a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Dingdang Health Technology Group (9886) the key facts are: market cap HK
Track Dingdang Health Technology Group's full fundamentals live
Get Dingdang Health Technology Group's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.